An interventional study of Masimo SafetyNet Alert (MSNA) in Opioid Use, sponsored by Masimo Corporation. Terminated at 1 site in Canada. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-08-13.
Sponsored by Masimo Corporation · Not applicable, Interventional, and Device feasibility
This Clinical Trial will evaluate the Feasibility and Acceptability of Oxygen Saturation Monitoring using Masimo SafetyNet Alert (MSNA) in a Supportive Housing Program
Masimo Corporation is the lead sponsor of 103 studies on the registry; 1 is open to participants now.
Of its 78 completed or terminated interventional studies of FDA-regulated products, 65 (83%) have results posted.
Counted across the registry records on this site, refreshed daily.
Inclusion Criteria for Client Participants:
Inclusion Criteria for Staff Participants:
Exclusion Criteria for Client Participants:
Exclusion Criteria for Staff Participants:
-None
All subjects who are enrolled into the test group (excluding staff participants) and participate in data collection receive the noninvasive Masimo SafetyNet Alert (MSNA)
Device: Masimo SafetyNet Alert (MSNA)
This study will explore the feasibility of implementing the Masimo SafetyNet Alert (MSNA) oxygen saturation monitoring system and the acceptance of MSNA by individuals living in a supportive housing program, who inject opioids.
Evaluation of Feasibility of Masimo SafetyNet Alert (MSNA) in a Supportive Housing Program
Number of participants who demonstrated feasibility of MSNA in a supportive housing program
Time frame: 2-4 weeks
Evaluation of Feasibility of Masimo SafetyNet Alert (MSNA) in a Supportive Housing Program
Summarizing proportion of incomplete studies to evaluate the feasibility of Masimo SafetyNet Alert (MSNA) in a supportive housing program.
Time frame: 2-4 weeks
Evaluation of Feasibility of Masimo SafetyNet Alert (MSNA) in a Supportive Housing Program
Summarizing proportion of lost components to evaluate the feasibility of Masimo SafetyNet Alert (MSNA) in a supportive housing program.
Time frame: 2-4 weeks
No staff participants were enrolled in this study prior to termination.
| Milestone | Masimo SafetyNet Alert (MSNA) |
|---|---|
| Started | 10 |
| Completed | 6 |
| Not completed | 4 |
| Withdrew: Death: unrelated to the device. the subject was enrolled but did not start any study activities | 1 |
| Withdrew: Physician decision | 1 |
| Withdrew: Withdrawal by subject | 2 |
Number of participants who demonstrated feasibility of MSNA in a supportive housing program
| participants | Masimo SafetyNet Alert (MSNA) |
|---|---|
| Evaluation of Feasibility of Masimo SafetyNet Alert (MSNA) in a Supportive Housing Program | 6 |
Summarizing proportion of incomplete studies to evaluate the feasibility of Masimo SafetyNet Alert (MSNA) in a supportive housing program.
| incomplete studies | Masimo SafetyNet Alert (MSNA) |
|---|---|
| Evaluation of Feasibility of Masimo SafetyNet Alert (MSNA) in a Supportive Housing Program | 4 |
Summarizing proportion of lost components to evaluate the feasibility of Masimo SafetyNet Alert (MSNA) in a supportive housing program.
| lost components | Masimo SafetyNet Alert (MSNA) |
|---|---|
| Evaluation of Feasibility of Masimo SafetyNet Alert (MSNA) in a Supportive Housing Program | 0 |
Collected over Entirety of study (60 days). Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Masimo SafetyNet Alert (MSNA) | 1/10 (10%) | 0/10 (0%) | 0/10 (0%) |
| Age, Categorical(Participants) | Masimo SafetyNet Alert (MSNA) |
|---|---|
| <=18 years | 0 |
| Between 18 and 65 years | 10 |
| >=65 years | 0 |
| Sex: Female, Male(Participants) | Masimo SafetyNet Alert (MSNA) |
|---|---|
| Female | 4 |
| Male | 6 |
| Race and Ethnicity Not Collected(Participants) | Masimo SafetyNet Alert (MSNA) |
|---|
Documents are hosted by the registry — open the source record to download them.
This study is terminated, as verified in Jul 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Masimo Corporation